International Symposium on Avian Influenza in April 2009
GLOBAL - The 7th International Symposium on Avian Influenza will be held at the University of Georgia on 5-8 April 2009.

Dalton Receives Distinguished Poultry Industry Award
US - Don Dalton, retired president of the US Poultry & Egg Association, was honoured by the Poultry Science Association as the recipient of the Merial Distinguished Poultry Industry Award.

Merial Names New Head of Global R&D
US - Ellen de Brabander, PhD., has been appointed Global Head of Merial Research and Development for Merial Limited. Dr de Brabander reports to José Barella, Merial’s Executive Chairman, and is a member of Merial’s executive leadership team.

Infectious Disease Control at VIV Europe
RUSSIA - A product range at the forefront of infectious disease control will be the theme for a presentation by Dr Stéphane Imbert at this year's VIV Europe trade fair in Moscow.

Merial's SAPO Licence Restored
Merial Animal Health has been given the go-ahead to restart making vaccines to protect animals from foot and mouth and bluetongue disease at its Pirbright Centre in the UK.

Merial Acquires New Zealand Animal Health Company
NEW ZEALAND - Merial Limited has acquired the New Zealand animal health products company Ancare. Merial is one of the world’s largest animal health companies.

Jose Barella To Succeed Jerry Belle As Executive Chairman of Merial
DULUTH - The Board of Directors of Merial Ltd., one of the world's leading animal health companies, announced that Jose Barella will succeed Jerry Belle as Executive Chairman of Merial, effective June 1st.

Merial, Pfizer Scoop Animal Pharm Awards
UK - Merial and Pfizer led the pack at Animal Pharm's inaugural Animal Health Industry Excellence Awards, held in London's Docklands on October 12th.

Merial Licenses Poultry Productivity Product
AUSTRALIA - Merial has finalised an exclusive sub-license agreement with Imugene which grants it the global rights to develop and sell Imugene’s poultry productivity enhancing product.

Merial Launches New H5N1 Avian Influenza Vaccine; provides new hope for avian flu epidemic
US - Merial today announced the introduction of a new inactivated vaccine, GALLIMUNE® Flu H5N9, developed and shown to be effective specifically for use against the highly pathogenic avian influenza virus H5N1 that has caused devastating economic losses...